Clinical Trial

A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Acute Kidney Injury (AKI) is the sudden and recent reduction in kidney function. This can be detected by measuring a rise in blood creatinine level or from a reduction in urine. Reasons for developing AKI, include dehydration, low blood pressure, medication and infection. When the kidneys stop working, there can be a build-up of toxins and fluid. It is extremely important to identify a patient's fluid status as too little can cause further damage to the kidneys and too much can be harmful. Assessment is varied and often inaccurate and there needs to be a standard approach to fluid assessment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-09-08; most recent amendment 2025-12-04.
Status change: Recruiting → Active, Not Recruiting 2025-06-23
Status change: Not Yet Recruiting → Recruiting 2023-12-08
Trial Details
NCT Number NCT05538351
Lead Sponsor University of Hertfordshire
Collaborators: East and North Hertfordshire NHS Trust
Conditions Acute Kidney Injury
Enrollment 120 participants
Start Date 2022-09-09
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-05